MAIA
Income statement / Annual
Last year (2024), MAIA Biotechnology, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, MAIA Biotechnology, Inc.'s net income was -$23.25 M.
See MAIA Biotechnology, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$10.01 M
|
$11.11 M
|
$8.93 M
|
$3.45 M
|
$1.41 M
|
$1.91 M
|
| General & Administrative Expenses |
$6.95 M
|
$9.07 M
|
$6.14 M
|
$4.29 M
|
$5.56 M
|
$5.01 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$6.95 M
|
$9.07 M
|
$6.14 M
|
$4.29 M
|
$5.56 M
|
$5.01 M
|
| Other Expenses |
$0.00
|
$0.00
|
$1.10 M
|
$43.67 K
|
$0.00
|
$0.00
|
| Operating Expenses |
$16.96 M
|
$20.18 M
|
$16.18 M
|
$7.79 M
|
$6.98 M
|
$6.92 M
|
| Cost And Expenses |
$16.96 M
|
$20.18 M
|
$16.18 M
|
$7.79 M
|
$6.98 M
|
$6.92 M
|
| Interest Income |
$318.37 K
|
$27.63 K
|
$1.87 K
|
$2.01 K
|
$0.00
|
$242.00
|
| Interest Expense |
$57.00
|
$0.00
|
$6.97 K
|
$827.54 K
|
$31.55 K
|
$0.00
|
| Depreciation & Amortization |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$6.98 M
|
$6.92 M
|
| EBITDA |
-$23.25 M |
-$19.77 M |
-$15.76 M |
-$11.75 M |
$0.00 |
$0.00 |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
-$6.30 M
|
$409.48 K
|
$406.92 K
|
-$4.79 M
|
$16.35 K
|
$242.00
|
| Income Before Tax |
-$23.25 M
|
-$19.77 M
|
-$15.77 M
|
-$12.58 M
|
-$6.96 M
|
-$6.92 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$23.25 M
|
-$19.77 M
|
-$15.77 M
|
-$12.50 M
|
-$6.64 M
|
-$6.49 M
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-1.05 |
-1.49 |
-1.7 |
-1.18 |
-0.62 |
-0.61 |
| EPS Diluted |
-1.05 |
-1.49 |
-1.7 |
-1.18 |
-0.62 |
-0.61 |
| Weighted Average Shares Out |
$22.20 M
|
$13.26 M
|
$9.28 M
|
$10.64 M
|
$10.64 M
|
$10.64 M
|
| Weighted Average Shares Out Diluted |
$22.20 M
|
$13.26 M
|
$9.28 M
|
$10.64 M
|
$10.64 M
|
$10.64 M
|
| Link |
|
|
|
|
|
|
